# CalciMedica (CALC) — Earnings

CALC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/calc/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$28.01 |
| EPS estimate | −$24.51 |
| EPS surprise | −14.29% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1534133/000095017025107334/ck0001534133-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$24.51 | −$28.01 | -14.29% | — | — |
| Q1 2025 | May 14, 2025 | −$21.48 | −$25.21 | -17.39% | — | — |
| Q4 2024 | Mar 27, 2025 | −$29.55 | −$25.91 | 12.32% | — | — |
| Q3 2024 | Nov 13, 2024 | −$39.39 | −$35.01 | 11.11% | — | — |
| Q2 2024 | Aug 12, 2024 | −$40.20 | −$25.21 | 37.28% | — | — |
| Q4 2023 | Mar 28, 2024 | −$61.10 | −$50.42 | 17.48% | — | — |
| Q3 2023 | Nov 9, 2023 | −$79.83 | −$57.42 | 28.07% | — | — |
| Q2 2023 | Aug 10, 2023 | −$73.18 | −$77.73 | -6.22% | — | — |
| Q1 2023 | Invalid Date | −$51.12 | −$1,640.76 | -3109.59% | — | — |
| Q3 2022 | Nov 10, 2022 | −$401.96 | −$450.98 | -12.20% | — | — |
| Q2 2022 | Aug 11, 2022 | −$394.12 | −$372.55 | 5.47% | — | — |
| Q1 2022 | May 10, 2022 | −$374.51 | −$470.59 | -25.65% | $75,000.00 | — |
| Q4 2021 | Mar 10, 2022 | −$358.82 | −$401.96 | -12.02% | — | — |
| Q3 2021 | Nov 12, 2021 | −$362.75 | −$372.55 | -2.70% | — | — |
| Q2 2021 | Aug 11, 2021 | −$458.82 | −$352.94 | 23.08% | — | — |
| Q1 2021 | May 12, 2021 | −$450.98 | −$529.41 | -17.39% | — | — |
| Q4 2020 | Mar 5, 2021 | −$400.00 | −$431.37 | -7.84% | — | — |

## Frequently Asked Questions

### When did CalciMedica (CALC) last report earnings?

CalciMedica last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did CALC beat earnings estimates?

No. CalciMedica reported EPS of −$28.01 for Q2 2025 against a −$24.51 estimate — a 14.29% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).